Literature DB >> 18509168

Hairy cell leukemia: treatment successes in the past 25 years.

Harvey M Golomb1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18509168     DOI： 10.1200/JCO.2007.15.7420

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  "Hairy Cell Leukemia (HCL): 'Real World' Outcome".

Authors:  Archit Joshi; Manikandan Dhanushkodi; Prasanth Ganesan; Venkatraman Radhakrishnan; Krishnarathinam Kannan; Nikita Mehra; Jayachandran Perumal Kalaiyarasi; S Krupashankar; Shirley Sundersingh; T S Ganesan; T G Sagar
Journal:  Indian J Hematol Blood Transfus       Date:  2019-09-28       Impact factor: 0.900

2.  Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia.

Authors:  Farhad Ravandi; Susan O'Brien; Jeffrey Jorgensen; Sherry Pierce; Stefan Faderl; Alessandra Ferrajoli; Charles Koller; Pramoda Challagundla; Sergernne York; Mark Brandt; Rajyalakshmi Luthra; Jan Burger; Deborah Thomas; Michael Keating; Hagop Kantarjian
Journal:  Blood       Date:  2011-08-05       Impact factor: 22.113

3.  IFN-α mediates the development of autoimmunity both by direct tissue toxicity and through immune cell recruitment mechanisms.

Authors:  Nagako Akeno; Eric P Smith; Mihaela Stefan; Amanda K Huber; Weijia Zhang; Mehdi Keddache; Yaron Tomer
Journal:  J Immunol       Date:  2011-03-14       Impact factor: 5.422

Review 4.  How I treat hairy cell leukemia.

Authors:  Michael R Grever
Journal:  Blood       Date:  2009-10-20       Impact factor: 22.113

5.  Rituximab in the treatment of non-Hodgkin's lymphoma.

Authors:  Beate Hauptrock; Georg Hess
Journal:  Biologics       Date:  2008-12

6.  Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines.

Authors:  Britta Moens; Christophe Pannecouque; Giovanni López; Michael Talledo; Eduardo Gotuzzo; Ricardo Khouri; Achiléa Bittencourt; Lourdes Farré; Bernardo Galvão-Castro; Anne-Mieke Vandamme; Johan Van Weyenbergh
Journal:  Virol J       Date:  2012-08-23       Impact factor: 4.099
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.